Cerenome, Inc. (CNSY) vs Dare Bioscience, Inc. (DARE)

Cerenome, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Cerenome, Inc. and Dare Bioscience, Inc. are of similar size ($14.5M and $14.3M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −21.0%. Cerenome, Inc. has the higher net margin (−526.5% vs −804.3%) and the lower return on invested capital (−532.8% vs 0.00%). Across the 16 metrics below, Cerenome, Inc. leads on 8 and Dare Bioscience, Inc. on 8.

Valuation

Metric CNSY DARE Biotechnology median
P/E n/m n/m 7.88
P/S 3.27 8.50 11.47
P/B 2.51 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.07 0.74
EV/Sales 2.89 (0.47) 10.73
Earnings yield (168.84%) (89.74%) (28.84%)
Free cash flow yield (175.55%) (99.90%) (23.03%)

Profitability

Metric CNSY DARE Biotechnology median
Gross margin 100.00% 58.84% 65.16%
Operating margin (628.12%) (813.35%) 0.00%
Net margin (526.48%) (804.33%) 0.00%
Free cash flow margin (560.29%) (849.36%) 0.00%
Return on equity (520.84%) 165.29% (57.72%)
Return on assets (181.53%) (62.16%) (49.22%)
Return on invested capital (532.77%) 0.00% 0.00%

Growth

Metric CNSY DARE Biotechnology median
Revenue growth (TTM) (20.95%) 7,817.51% 5.64%
EPS growth (last fiscal year) 82.79% (150.00%) —
Revenue growth, 5-year CAGR (5.72%) 66.71% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSY DARE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.37 0.99 4.73
Net debt to EBITDA 0.83 2.07 0.96

Dividend

Metric CNSY DARE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CNSY DARE Biotechnology median
Market cap 14.26m 14.50m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack